Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 1 / Phase 2	2026-05-26		NCT06631092

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
NEC Bio B.V	2
NEC Bio Therapeutics	2

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Center for Tumor Diseases Heidelberg	Heidelberg	Germany	1
University Clinic Erlangen	Erlangen	Germany	3

Clinical trials